Kedrion Biopharma Inc. supported the National Bleeding Disorders Foundation’s (NBDF) 76th Annual Bleeding Disorders Conference (BDC), underscoring its commitment to supporting the bleeding disorders community. The event took place from September 12-14, 2024, in Atlanta (Georgia, USA), and brought together individuals with bleeding disorders, their families, healthcare professionals, and researchers from across the country.
Kedrion hosted several events and activities designed to engage with attendees and share information about its therapies. Highlights were a Campfire presentation on the results of the Hereditary Factor X in Americas survey, the 2nd Annual Plasminogen Deficiency Roundtable and The Ultra Rare Networking Hour, a dedicated space for individuals with ultra-rare bleeding and or clotting disorders and their support network to connect and build relationships. This initiative provided a platform for sharing experiences and resources.
“At Kedrion, every employee is united by a powerful mission: to amplify the voices of patients with rare diseases and to continually improve their journey and care. Together, our global commitment ensures that every step forward is a step towards a brighter, more hopeful future” said Bob Rossilli, CCO, Global Business and US General Manager of Kedrion.
Kedrion’s participation in the NBDC reflects the company’s commitment to improving the lives of individuals with rare diseases. By providing support, education, and access to innovative therapies, Kedrion is working to ensure that patients have the resources they need to live full and healthy lives.
